Monday, August 17, 2015

Pharmaceutical Prices, Patents, and the Truth About the FDA

Ogco fda 1006

( In this article by economist Jeffrey Sachs, pharmaceutical company Gilead is taken to task for selling its hepatitis C cure, Sofosbuvir (sold as Sovaldi), at a price of $84,000 per course of treatment. Sachs says that the actual production cost of Sofosbuvir is about $100.

Sachs says that Gilead is "bilking the taxpayer" by charging the government prices far above production costs — and government is probably paying for most of the Sofosbuvir drugs. Sachs further complains that people will die because of Gilead's refusal to cut the price to something more affordable.

Read full article here.


Post a Comment

Copyright © 2014. World Issues Truth . All Rights Reserved
Home | | Contact Us | Privacy policy | About | | Site map
Design by Herdiansyah . Published by Borneo Templates